This page is no longer updated.
It was archived on 8 July 2008 and is kept for historical purposes only. The latest content is available at http://www.who.int/selection_medicines/en/

13th Expert Committee on the Selection and Use of Essential Medicines
31 March to 3 April 2003

 

Draft agenda (version, 24 March 2003)

 

Comments on the draft agenda items are welcomed, especially on the applications for addition, change or deletion of medicines relating to the Model List.  Please contact:

 

The Secretary of the Expert Committee on the Selection and Use of Essential Medicines

Policy, Access and Rational Use

Essential Drugs and Medicines Policy

World Health Organization

20 Avenue Appia

CH-1211 Geneva 27

hogerzeilh@who.int

 

  1. Update on current activities (19 March 2003)

  • Dissemination of Report of 12th Expert Committee

  • Report on 25th Anniversary of Model List of Essential Medicines

  • WHO Essential Medicines Library

  • WHO Model Formulary

  • Review of essential medicines for reproductive health

  • Review of New Emergency Health Kit

  2. Applications for addition (21 March 2003)

  • Amodiaquine

  • Azithromycin

  • Ibuprofen paediatric formulation

  • Insulin semilente

  • Miconazole buccal tablet (re-application)

  • Misoprostol

  • Valaciclovir

  3. Application for deletion (26 February 2003)

  • Ethinylestradiol + levonorgestrel tablet, 50 micrograms + 250 micrograms (pack of four)

  • Nonoxynol

  4. Application for addition of information (21 January 2003)

  • Anti-leprosy medicines

  5. Application for change (14 February 2003)

  • Levonorgestrel tablet, 1.5mg (additional dosage form)

  • Oral Rehydration Salts (change in formula)

  • Streptokinase (dosage modification)

  6. Fast-track procedure for deletion (18 February 2003)

  • Description of method used

  • Proposals for fast-track deletion 

  • Proposals for priority review

  7. Review of Core and Complementary Listing (22 January 2003)

  • Description of method used; proposed definition

  • Proposals for change in core and/or complementary status

  8. Review of use of Square Box Symbol (15 January 2003)

  • Description of method used

  • Proposals for deletion of square box symbol

  • Proposals for priority review

  9. Review of section 12.3 Antihypertensive Medicines (24 March 2003)

  • Update on WHO Hypertension Guidelines

  • Proposals for addition, change and/or deletion

  • Magnesium sulphate as antihypertensive for treatment of pre-eclampsia

  • Calcium antagonists: message

10. Proposals for priority review for next meeting(s) (17 March 2003)

  • Analysis of the WHO Model List and 25 National Essential Drugs Lists

  • Grand total summary: drugs sorted by alphabetical order: occurrence in 25 National Drugs Lists

  • Grand total summary: drugs sorted by frequency: occurrence in 25 National Drugs Lists

  • Spreadsheet 1: Additions and deletions to WHO Model List 1979-2002

  • Spreadsheet 2: Comparative analysis of WHO Lists 1977-2002

  • Spreadsheet 3: Grand total A summary 25 national lists

  • Spreadsheet 4: Grand total B summary 15 national lists

11. Review of activities to promote rational drug use (19 March 17 March 2003)

  • Update on activities to contain antimicrobial resistance

  • Guidelines for Drugs and Therapeutic Committees

  • WHO database on rational drug use

Back to the EML Expert Committee Resources Menu

See also the Essential Medicines Library